Vertex is broadening its portfolio.
These stocks could be near major inflection points.
Low risk and high-reward potential? These stocks could offer both.
The biotech just added another potential growth driver to its pipeline.
Vertex just laid claim to an asset that might be very valuable.
Vertex Pharmaceuticals' $4.9 billion purchase of Alpine Immune Sciences probably won't be the last acquisition of a company focused on kidney disease.
The S&P 500 Index ($SPX ) (SPY ) Thursday closed up +0.74%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.01%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +1.65%. Stock indexes...
Stocks that traded heavily or had substantial price changes on Thursday: Fastenal, CarMax fall; Alpine Immune Sciences, Arvinas rise
The S&P 500 Index ($SPX ) (SPY ) is up +0.63%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.02%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.26%. Stock indexes are higher even as bond...
The S&P 500 Index ($SPX ) (SPY ) this morning is up +0.04%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.18%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.36%. Stock indexes this morning...